Name | Gosudarstvennoe unitarnoe predpriyatie RESPUBLIKI MORDOVIYA "FARMATSIYA" |
|---|
INN | 1300002949 |
|---|
KPP | 132701001 |
|---|
OGRN | 1021301115516 |
|---|
OKPO | 1967253 |
|---|
Address | 430034, Respublika Mordoviya, g Saransk, ul Promyshlennaya 1-ya, d. D. 8 |
|---|
Phone | Contact details |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 47.73 | Core activity | Retailing drugs in specialized stores (pharmacies) | | 21.20.1 | Additional activity | Production of drugs | | 26.70.1 | Additional activity | Manufacture of optical instruments and photographic equipment | | All types of activities | | 46.46.1 | Additional activity | Wholesale of furniture, carpets and lighting equipment | | 49.41 | Additional activity | Furniture stores | | 52.10 | Additional activity | Activity Warehousing and storage | | 68.20.2 | Additional activity | Renting and operating of own or leased commercial properties and non- residential buildings |
Registration date | 23.10.2002 |
|---|
Registering department | Administratsiya goroda Saranska Respubliki Mordoviya |
|---|
|
GUP RESPUBLIKI MORDOVIYA "FARMATSIYA" (Mordovia, Republic; INN 1300002949) was registered on 23 Oct 2002. The company's authorized capital as of July 1, 2012 was 56636000 rub. Type of ownership of GUP RESPUBLIKI MORDOVIYA "FARMATSIYA" - Representative offices and branches. Form of ownership of GUP RESPUBLIKI MORDOVIYA "FARMATSIYA" - Property of constituent entities of the Russian Federation. Principal activities of GUP RESPUBLIKI MORDOVIYA "FARMATSIYA": retailing drugs in specialized stores (pharmacies) (47.73), production of drugs (21.20.1), manufacture of optical instruments and photographic equipment (26.70.1). |
Economic indicators2023
Net profit (RAS) of GUP RESPUBLIKI MORDOVIYA FARMATSIYA grew over 2023 1.81 times to 2.20 million RUB from 1.21 million RUB over 2022, the company informed. Revenue increased in the accounting period by 6.67% to 2.20 billion RUB from 2.07 billion RUB over 2022; cost of goods sold grew by 8.09% to 1.82 billion RUB from 1.69 billion RUB; sales loss made up 16.39 million RUB compared to sales profit of 75.99 million RUB. 2022
Net profit (RAS) of GUP RESPUBLIKI MORDOVIYA FARMATSIYA grew over 2022 5.52 times to 1.21 million RUB from 220.00 thousand RUB over 2021, the company informed. Revenue increased in the accounting period by 11.41% to 2.07 billion RUB from 1.86 billion RUB over 2021; cost of goods sold grew by 8.45% to 1.69 billion RUB from 1.56 billion RUB; sales profit went up 3.71 times to 75.99 million RUB from 20.46 million RUB. 2021
Net profit (RAS) of GUP RESPUBLIKI MORDOVIYA FARMATSIYA grew over 2021 by 10.00% to 220.00 thousand RUB from 200.00 thousand RUB over 2020, the company informed. Revenue increased in the accounting period by 4.41% to 1.86 billion RUB from 1.78 billion RUB over 2020; cost of goods sold grew by 6.71% to 1.56 billion RUB from 1.46 billion RUB; sales profit fell 4.55 times to 20.46 million RUB from 93.10 million RUB. 2020
Net profit (RAS) of GUP RESPUBLIKI MORDOVIYA FARMATSIYA grew over 2020 by 42.86% to 200.00 thousand RUB from 140.00 thousand RUB over 2019, the company informed. Revenue increased in the accounting period 1.57 times to 1.78 billion RUB from 1.13 billion RUB over 2019; cost of goods sold grew 1.58 times to 1.46 billion RUB from 921.57 million RUB; sales profit went up 2.68 times to 93.10 million RUB from 34.69 million RUB. 2019
Net profit (RAS) of GUP RESPUBLIKI MORDOVIYA FARMATSIYA grew over 2019 by 16.67% to 140.00 thousand RUB from 120.00 thousand RUB over 2018, the company informed. Revenue increased in the accounting period by 48.84% to 1.13 billion RUB from 759.31 million RUB over 2018; cost of goods sold grew 1.70 times to 921.57 million RUB from 541.66 million RUB; sales profit fell by 41.87% to 34.69 million RUB from 59.67 million RUB. 2018
Net profit (RAS) of GUP RESPUBLIKI MORDOVIYA FARMATSIYA grew over 2018 44.13 times to 51.81 million RUB from 1.17 million RUB over 2017, the company informed. Revenue increased in the accounting period 1.77 times to 759.31 million RUB from 429.95 million RUB over 2017; cost of goods sold grew 2.10 times to 541.66 million RUB from 257.83 million RUB; sales profit went up 2.22 times to 59.67 million RUB from 26.85 million RUB. 2017
Net profit (RAS) of GUP RESPUBLIKI MORDOVIYA FARMATSIYA dropped in 2017 274.99 times to 1.17 million RUB from 322.84 million RUB over the same period in 2016, the company informed. Revenue increased in the accounting period by 13.39% to 429.95 million RUB from 379.17 million RUB over 2016; cost of goods sold decreased by 0.74% to 257.83 million RUB from 259.74 million RUB; sales profit made up 26.85 million RUB compared to sales loss of 30.51 million RUB. 2016
Net profit (RAS) of GUP RESPUBLIKI MORDOVIYA FARMATSIYA made up 322.84 million RUB over 2016 compared to net loss of 44.14 million RUB over 2015, the company informed. Revenue decreased in the accounting period by 37.30% to 379.17 million RUB from 604.77 million RUB in 2015; cost of goods sold decreased by 38.81% to 259.74 million RUB from 424.51 million RUB; sales loss decreased by 26.55% to 30.51 million RUB from 41.54 million RUB. 2014
Net loss (RAS) of GUP Respubliki Mordoviya Farmatsiya dropped over 2014 by 11.14% to 63.87 million RUB from 71.87 million RUB KAgent.Entities.Balance, the company informed. Revenue decreased in the accounting period by 4.58% to 812.53 million RUB from 851.50 million RUB in 2013; cost of goods sold decreased by 6.33% to 581.31 million RUB from 620.58 million RUB; sales loss decreased by 32.43% to 25.10 million RUB from 37.15 million RUB. 2013
Net loss (RAS) of GUP Respubliki Mordoviya Farmatsiya dropped over 2013 2.08 times to 256.00 thousand RUB from 532.00 thousand RUB KAgent.Entities.Balance, the company informed. Revenue increased in the accounting period by 30.95% to 7.42 million RUB from 5.67 million RUB over 2012; cost of goods sold grew by 28.02% to 5.76 million RUB from 4.50 million RUB; sales loss decreased 2.28 times to 210.00 thousand RUB from 479.00 thousand RUB. 2012
Net loss (RAS) of GUP RM Farmaciya increased by 29.76% to 64.70 million RUB from 49.86 million RUB over 2011, the company informed. Cost of goods sold grew by 7.04% to 291.79 million RUB from 272.60 million RUB; sales loss grew by 48.83% to 32.63 million RUB from 21.92 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|